Vaccine
Gardasil 9
Indication
Age 9 or above
Usage
Reduce 90% of cervical cancer, 90-95% of anal cancer and their precancerous growth
Details
Manufacturer
MSD
HK Registration Number
HK-64239
Registration
HK registration since 2015
Price
HK$1800
Dosage & Schedule
Age 9-14: 2 doses series on a 0-,6-month schedule
Age 15 or over: 3 doses series on a 0-,2-,6-month schedule
Peak Incidence Age
Age 26-30, and Age 46-55
Characteristics
- Provide extra 85-90% of protection against Vaginal and Cervical cancer when compare to other HPV vaccine.
High Risk Groups
Recurrent HPV infection, Immunodeficient individual, Smoker
Common Side Effects
Mild redness and swelling at injection site. Occasionally, fever or headache might occur
Contraindication
- Hypersensitivity, including severe allergic reactions to yeast (a vaccine component), or after a previous dose of GARDASIL 9 or GARDASIL
- Pregnant women
- Those with fever or suffering from moderate to severe illness
Vaccine
Bexsero
Indication
2 months old onwards
Usage
Prevent invasive meningococcal disease by Neisseria meningitidis B
Details
Manufacturer
GSK
HK Registration Number
HK-66268
Registration
HK registration since 2019
Price
HK$1500
Dosage & Schedule
2-23 months old : 3 doses, at least 2 months between each dose
2 years old and above : 2 doses, at least 1 month apart
Peak Incidence Age
Aged below 1, and 16-23
Characteristics
- The only Meningococcal B vaccine indicated for paediatric patients
- Though Hong Kong has a low meningococcal infection rate, vaccination is still recommended for high-risk group
High Risk Groups
Immunodeficient individual, borders in dormitorie, students planning for overseas studies and travellers to high-risk countries
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), unusual crying, irritability, loss of appetite, vomiting, diarrhea, somnolence and rash
Contraindication
- Severe allergic reaction to any component of this vaccine
Vaccine
Quadrivalent Flu Vaccine
Indication
Aged 6 months onwards
Usage
Influenza A&B and its complications
Details
Manufacturer
Sanofi Pasteur, GSK
HK Registration Number
HK-65577, HK-62234
Registration
HK registration
Price
HK$280
Dosage & Schedule
1 dose annually
2 doses with minimum interval of 4 weeks for child below aged 9 who has never received any seasonal influenza vaccine
Peak Incidence Age
Under 12 and over 50 years old
Characteristics
- Protection begin 2 weeks after vaccination
High Risk Groups
Children younger than 5, but especially children younger than 2 years, elderly and those with weaken immunity.
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability and headache
Contraindication
- Severe allergic reaction to any component of this vaccine
Vaccine
Flumist
Indication
Aged 2-49
Usage
Influenza A&B and its complications
Details
Manufacturer
AstraZeneca
HK Registration Number
HK-65690
Registration
HK registration 2018
Price
HK$440
Dosage & Schedule
1 dose annually
2 doses with minimum interval of 4 weeks for child below aged 9 who has never received any seasonal influenza vaccine
Peak Incidence Age
Under 12
Characteristics
- Protection begin 2 weeks after vaccination
High Risk Groups
Children younger than 5 years old
Common Side Effects
Fever, runny nose, nasal congestion, sore throat
Contraindication
- Severe allergic reaction to any component of Flumist
- Children aged 2 to 5 years with history recurrent wheezing
- Asthma sufferer and pregnant lady
- Concomitant aspirin therapy
Vaccine
Nimenrix
Indication
6 weeks and above
Usage
Prevent invasive meningococcal disease caused by Neisseria meningitidis A, C, Y, W-135
Details
Manufacturer
Pfizer
HK Registration Number
HK-62095
Registration
HK registration since 2013
Price
HK$1100
Dosage & Schedule
For aged 6 weeks to 5 months: 3 doses, minimum 2-month interval between first two doses, then 1 booster dose at 12 months old or above
For aged 6-11 months: 2 doses with minimum 2-month interval and second dose given at 12 months old or above
Over 12 months : 1 dose
Peak Incidence Age
Under 12 months, and between 16-23 years old
Characteristics
- Contain extra Y and W-135 strain than the China meninococcal vaccine
- Can be given as early as 6 weeks old
- Though Hong Kong has a low meningococcal infection rate, vaccination is still recommended for high-risk group
High Risk Groups
Under 1 year old, borders in dormitories, students planning for overseas studies and travellers to high-risk countries
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, loss of appetite, vomiting, diarrhea and somnolence
Contraindication
- Severe allergic reaction to any component of this vaccine
Vaccine
MenQuadfi
Indication
12 months old and above
Usage
Prevent invasive meningococcal disease caused by Neisseria meningitidis A, C, Y, W-135
Details
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-67394
Registration
FDA (2020), EMA (2020), HK registration (2022)
Price
HK$1100
Dosage & Schedule
Over 12 months : 1 dose
Peak Incidence Age
1-5 years old and 16-23 years old
Characteristics
- The only ACWY vaccine approved by both FDA & EMA in Hong Kong
High Risk Groups
Borders in dormitories, students planning for overseas studies and travellers to high-risk countries
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, loss of appetite, vomiting, diarrhea and somnolence
Contraindication
- Severe allergic reaction to any component of this vaccine
Vaccine
Imojev
Indication
From 9 months onward
Usage
Prevention of Japanese encephalitis
Details
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-62787
Registration
Australia TGA (2010), Hong Kong CHP (2014)
Price
HK$1850
Dosage & Schedule
9 months to 17 years old: 2 doses series, with interval of 12-24 months
18 years old and above: 1 dose only
Peak Incidence Age
Summer and rainy season
Characteristics
- 99.2% of young children (9 to 18 months old) get protection 28 days after receiving one dose of Japanese encephalitis vaccine
High Risk Groups
Newborn to 14 years old , People who stay outdoor most of the time
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), unusual crying, loss of appetite, headache, vomiting and somnolence
Contraindication
- Infant under 9 months old
- Severe allergic reaction to any component of this vaccine
Vaccine
RotaTeq
Indication
From 6 to 32 weeks infants
Usage
Rotavirus gastroenteritis caused by G1, G2, G3, G4 & G9 types
Details
Manufacturer
MSD
HK Registration Number
HK-55037
Registration
HK registration since 2006
Price
HK$520
Dosage & Schedule
3 doses with at least 4 weeks apart, first dose to be taken before 12 weeks old
Peak Incidence Age
6 to 24 months
Characteristics
- Pentavalent vaccine
High Risk Groups
4 to 23 months
Common Side Effects
Fever, irritability, loss of appetite, vomiting, diarrhea
Contraindication
- Severe allergic reaction to any component of this vaccine
- History of intussusception or uncorrected congenital malformation of the gastrointestinal tract that would predispose the infant to intussusception
- History of severe combined immunodeficiency disease
Vaccine
Rotarix
Indication
From 6 to 24 weeks infants
Usage
Rotavirus gastroenteritis caused by G1 and non-G1 types
Details
Manufacturer
GSK
HK Registration Number
HK-54546
Registration
HK registration since 2006
Price
HK$780
Dosage & Schedule
2 doses with at least 4 weeks apart, first dose to be taken before 20 weeks old
Peak Incidence Age
6 to 24 months
Characteristics
- Early protction, infant can finished the 2 doses course as early as 10 weeks old
High Risk Groups
4 to 23 months
Common Side Effects
Fever, irritability, loss of appetite, vomiting, diarrhea
Contraindication
- Severe allergic reaction to any component of this vaccine
- History of intussusception or uncorrected congenital malformation of the gastrointestinal tract that would predispose the infant to intussusception
- History of severe combined immunodeficiency disease
Vaccine
Infanrix-Hexa
Indication
From 6 weeks onwards
Usage
Prevention of diphtheria, tetanus, pertussis, poliomyelitis, invasive disease due to Haemophilus influenzae type b and hepatitis B
Details
Manufacturer
GSK
HK Registration Number
HK-64010
Registration
HK registration since 2015
Price
HK$800
Dosage & Schedule
4 doses at aged 2, 4, 6 months and 15-18 months
Peak Incidence Age
Infant
Characteristics
- 30-40% more Pertussis prevention than traditional DTaP-IPV vaccine
- Combine 5in1 & Hepatitis B vaccine, can reduce the total number of injections from 10 to 4
High Risk Groups
Infant
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), injection nodule, unusual crying, irritability, loss of appetite, vomiting, diarrhea and somnolence
Contraindication
- Severe allergic reaction to any component of this vaccine
- Encephalopathy of unknown cause, occurring within 7 days following previous vaccination with a pertussis containing vaccine
Vaccine
Pentaxim
Indication
From 2 months onward
Usage
Prevention of diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b.
Details
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-56018
Registration
HK registration since 2007
Price
HK$780
Dosage & Schedule
4 doses at 2, 4, 6 months and 15-18 months
Peak Incidence Age
Infant
Characteristics
- Combine DTaP-IPV & Hib vaccine, can reduce the total number of injections from 8 to 4
High Risk Groups
Infant
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), injection nodule, unusual crying, irritability, loss of appetite, vomiting, diarrhea and somnolence
Contraindication
- Severe allergic reaction to any component of this vaccine
- Encephalopathy of unknown cause, occurring within 7 days following previous vaccination with a pertussis containing vaccine
Vaccine
Act-HIB
Indication
2 months to 5 years old
Usage
Prevention of Haemophilus influenza type b infection
Details
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-37568
Registration
HK registration since 1994
Price
HK$350
Dosage & Schedule
For aged 1.5-6 months: 4 doses with minimum 4-week interval for the first three doses, fourth dose at least 8 weeks after third dose and at 12 months old or above
For aged 7-11 months: 3 doses with minimum 4-week interval for the first two doses, third dose at least 8 weeks after second dose and at 12 months old or above
For aged 12-14 months: 2 doses with minimum 8-week interval
For aged 15-59 months: 1 dose
Peak Incidence Age
Infant
Characteristics
- To reduce the number of injections, 5-in-1 or 6-in-1 vaccine can be considered as they already included this vaccine
High Risk Groups
3 months to 3 years old
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, loss of appetite and somnolence
Contraindication
- Severe allergic reaction to any component of this vaccine
Vaccine
Vaxneuvance 15
Indication
From 6 weeks onwards
Usage
Prevention of invasive disease caused by S.pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F
Details
Manufacturer
MSD
HK Registration Number
HK-67575
Registration
HK registration since 2022
Price
HK$1600
Dosage & Schedule
For babies: 4 doses at aged 2, 4, 6 months and 12-15 months
For aged over 18: 1 dose
Peak Incidence Age
Below 2 and above 65 years old
Characteristics
- PCV15 includes all PCV13 serotypes plus 22F and 33F
- PCV13 and PCV15 can be used interchangeably
High Risk Groups
Infant, immunodeficient individual, functional or anatomic asplenia, cochlear implants
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, loss of appetite, vomiting, diarrhea, upper respiratory tract infection, rash, eczema and itching
Contraindication
- Severe allergic reaction to any component of this vaccine or any diphtheria toxoid-containing vaccine
Vaccine
Prevenar 13
Indication
From 6 weeks onwards
Usage
Prevention of invasive disease caused by S.pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F
Details
Manufacturer
Pfizer
HK Registration Number
HK-59600
Registration
HK registration since 2010
Price
HK$1200
Dosage & Schedule
For aged 6 weeks to under 6 months: 4 doses at aged 2, 4, 6 months and 12-15 months
For aged over 6 to under 12 months: 3 doses (dose 1 & 2 with minimum interval of 4 weeks; dose 2 & 3 with minimum interval of 8 weeks)
For aged over 12 to under 24 months: 2 doses with minimum interval of 8 weeks
For aged over 2: 1 dose
Peak Incidence Age
Below 2 and above 65 years old
Characteristics
- Conjugate vaccine can promote immune memory and provide long-term protection
- Contain extra strains of protection over Prevnar and Synflorix
High Risk Groups
Infant, immunodeficient individual, functional or anatomic asplenia, cochlear implants
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, loss of appetite, vomiting, diarrhea, upper respiratory tract infection, rash, eczema and itching
Contraindication
- Severe allergic reaction to any component of this vaccine or any diphtheria toxoid-containing vaccine
Vaccine
ProQuad
Indication
From 12 months onward
Usage
Prevention of measles, mumps, rubella, and varicella
Details
Manufacturer
MSD
HK Registration Number
HK-54831
Registration
HK registration since 2006
Price
HK$800
Dosage & Schedule
2 doses with 3 months interval
Peak Incidence Age
Aged 5-10
Characteristics
- Early protection from 15 months old onwards
High Risk Groups
Young child, Pregnant women
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, vomiting, diarrhea, upper respiratory tract infection, rash and eczema
Contraindication
- Pregnancy
- Severe allergic reaction to any component of this vaccine
- Immunodeficiency
Vaccine
Priorix
Indication
From 12 months onwards
Usage
Prevention of meales, mumps and rubella
Details
Manufacturer
GSK
HK Registration Number
HK-43861
Registration
HK registration since 2015
Price
HK$600
Dosage & Schedule
2 doses with 3 months interval
Peak Incidence Age
Age 5-10
Characteristics
- Early protection from 15 months old onwards
High Risk Groups
Young child, Pregnant women
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), upper respiratory tract infection and rash
Contraindication
- Pregnancy
- Severe allergic reaction to any component of this vaccine
- Immunodeficiency
Vaccine
Varivax
Indication
From 12 months old onwards
Usage
Prevention of chickenpox
Details
Manufacturer
MSD
HK Registration Number
HK-39958
Registration
HK registration since 1996
Price
HK$600
Dosage & Schedule
2 doses with at least 1 month interval
Peak Incidence Age
Age 10 and below
Characteristics
- Early protection from 15 months old onwards
High Risk Groups
Young child, Pregnant women
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, vomiting, diarrhea, upper respiratory tract infection, rash and eczema
Contraindication
- Pregnancy
- Severe allergic reaction to any component of this vaccine
- Immunodeficiency
Vaccine
Havrix 720 Junior
Indication
12 months of age and older
Usage
Child Hepatitis A virus
Details
Manufacturer
GSK
HK Registration Number
HK-42693
Registration
HK registration since 1997
Price
HK$420
Dosage & Schedule
2 doses with 6 -12 months apart
Peak Incidence Age
Aged 9-12 and adolescence. Incidence increase with age
Characteristics
- Protecton against Hepatitis A virus starts 28 days after 1st vaccination
High Risk Groups
Child care centre attendee and children who have started eating high-risk food such as fish and shellfish, Travellers to endemic areas of hepatitis A, Persons with chronic liver diseases.
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, loss of appetite, vomiting, diarrhea, headache, somnolence and arthralgia
Contraindication
- Severe allergic reaction to any component of this vaccine
Vaccine
Engerix-B 10
Indication
From birth
Usage
Child Hepatitis B virus
Details
Manufacturer
MSD
HK Registration Number
HK-50265
Registration
HK registration since 2002
Price
HK$400
Dosage & Schedule
3 doses: 1-month interval between first and second doses, and third dose 5 months after second dose
Peak Incidence Age
At birth
Characteristics
- Full response occurs in about 90–95% of individuals
High Risk Groups
Babies born to carrier mothers. People who share needles, syringes, or other drug-injection equipment. Travellers to regions with increased rates of hepatitis B. People with chronic liver disease, kidney disease, HIV infection, or diabetes
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability and headache
Contraindication
- Severe allergic reaction to any component of this vaccine
Vaccine
Typhim VI
Indication
2 years and above
Usage
Prevention of typhoid
Details
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-36827
Registration
HK registration since 1993
Price
HK$500
Dosage & Schedule
The vaccine should be given at least two weeks prior to departure . Revaccination should be considered every three years for those at continuous risk of infection.
Peak Incidence Age
Those going to typhoid endemic areas
Characteristics
- Antibodies appear after approximately 7 to 15 days after the injection. Persistence of the antibody response is at least 3 years.
High Risk Groups
Those going to typhoid endemic areas, in particular long-stay travellers and those visiting rural areas where food and beverage choices may be limited.
Common Side Effects
Mild redness and swelling at injection site
Contraindication
- Fever
- Severe allergic reaction (e.g. anaphylaxis) to any component of Typhim VI
Vaccine
Arexvy
Indication
Over 60 years old
Usage
RSV infection
Details
Manufacturer
GSK
HK Registration Number
HK-67997
Registration
FDA, EMA, HK registration since 2023
Price
HK$3000
Dosage & Schedule
Only 1 injection
Peak Incidence Age
Over 60 years old
Characteristics
- Protection efficacy of 80-95% for aged 60 and above, with at least one chronic illness
High Risk Groups
60 years old and above with at least one chronic illness (COPD, Diabetes, Heart disease)
Common Side Effects
Mild redness and swelling at injection site
Contraindication
- History of anaphylactic reaction to any component of the vaccine
Vaccine
Shingrix
Indication
Over 50 years old
Usage
Prevention of shingles
Details
Manufacturer
GSK
HK Registration Number
HK-66840
Registration
FDA Approved (2017), HK registration since 2021
Price
HK$2900
Dosage & Schedule
2 doses, at least 2 months apart
Peak Incidence Age
Over 50 years old
Characteristics
- Only shingles vaccine provide >90% protection in all segments studied
High Risk Groups
Previous shingles infection, immunodeficient individual
Common Side Effects
Mild redness and swelling at injection site. Occasionally, associated with syncope
Contraindication
- History of anaphylactic reaction to any component of the vaccine
Vaccine
Gardasil 9
Indication
Age 9 or above
Usage
Reduce 90% of cervical cancer, 90-95% of anal cancer and their precancerous growth
Details
Manufacturer
MSD
HK Registration Number
HK-64239
Registration
HK registration since 2015
Price
HK$1800
Dosage & Schedule
Age 9-14: 2 doses series on a 0-,6-month schedule
Age 15 or over: 3 doses series on a 0-,2-,6-month schedule
Peak Incidence Age
Age 26-30, and Age 46-55
Characteristics
- Provide extra 85-90% of protection against Vaginal and Cervical cancer when compare to other HPV vaccine.
High Risk Groups
Recurrent HPV infection, Immunodeficient individual, Smoker
Common Side Effects
Mild redness and swelling at injection site. Occasionally, fever or headache might occur
Contraindication
- Hypersensitivity, including severe allergic reactions to yeast (a vaccine component), or after a previous dose of GARDASIL 9 or GARDASIL
- Pregnant women
- Those with fever or suffering from moderate to severe illness
Vaccine
Bexsero
Indication
2 months old onwards
Usage
Prevent invasive meningococcal disease by Neisseria meningitidis B
Details
Manufacturer
GSK
HK Registration Number
HK-66268
Registration
HK registration since 2019
Price
HK$1500
Dosage & Schedule
2-23 months old : 3 doses, at least 2 months between each dose
2 years old and above : 2 doses, at least 1 month apart
Peak Incidence Age
Aged below 1, and 16-23
Characteristics
- The only Meningococcal B vaccine indicated for paediatric patients
- Though Hong Kong has a low meningococcal infection rate, vaccination is still recommended for high-risk group
High Risk Groups
Immunodeficient individual, borders in dormitorie, students planning for overseas studies and travellers to high-risk countries
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), unusual crying, irritability, loss of appetite, vomiting, diarrhea, somnolence and rash
Contraindication
- Severe allergic reaction to any component of this vaccine
Vaccine
Quadrivalent Flu Vaccine
Indication
Aged 6 months onwards
Usage
Influenza A&B and its complications
Details
Manufacturer
Sanofi Pasteur, GSK
HK Registration Number
HK-65577, HK-62234
Registration
HK registration
Price
HK$280
Dosage & Schedule
1 dose annually
2 doses with minimum interval of 4 weeks for child below aged 9 who has never received any seasonal influenza vaccine
Peak Incidence Age
Under 12 and over 50 years old
Characteristics
- Protection begin 2 weeks after vaccination
High Risk Groups
Children younger than 5, but especially children younger than 2 years, elderly and those with weaken immunity.
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability and headache
Contraindication
- Severe allergic reaction to any component of this vaccine
Vaccine
Flumist
Indication
Aged 2-49
Usage
Influenza A&B and its complications
Details
Manufacturer
AstraZeneca
HK Registration Number
HK-65690
Registration
HK registration 2018
Price
HK$440
Dosage & Schedule
1 dose annually
2 doses with minimum interval of 4 weeks for child below aged 9 who has never received any seasonal influenza vaccine
Peak Incidence Age
Under 12
Characteristics
- Protection begin 2 weeks after vaccination
High Risk Groups
Children younger than 5 years old
Common Side Effects
Fever, runny nose, nasal congestion, sore throat
Contraindication
- Severe allergic reaction to any component of Flumist
- Children aged 2 to 5 years with history recurrent wheezing
- Asthma sufferer and pregnant lady
- Concomitant aspirin therapy
Vaccine
Nimenrix
Indication
6 weeks and above
Usage
Prevent invasive meningococcal disease caused by Neisseria meningitidis A, C, Y, W-135
Details
Manufacturer
Pfizer
HK Registration Number
HK-62095
Registration
HK registration since 2013
Price
HK$1100
Dosage & Schedule
For aged 6 weeks to 5 months: 3 doses, minimum 2-month interval between first two doses, then 1 booster dose at 12 months old or above
For aged 6-11 months: 2 doses with minimum 2-month interval and second dose given at 12 months old or above
Over 12 months : 1 dose
Peak Incidence Age
Under 12 months, and between 16-23 years old
Characteristics
- Contain extra Y and W-135 strain than the China meninococcal vaccine
- Can be given as early as 6 weeks old
- Though Hong Kong has a low meningococcal infection rate, vaccination is still recommended for high-risk group
High Risk Groups
Under 1 year old, borders in dormitories, students planning for overseas studies and travellers to high-risk countries
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, loss of appetite, vomiting, diarrhea and somnolence
Contraindication
- Severe allergic reaction to any component of this vaccine
Vaccine
MenQuadfi
Indication
12 months old and above
Usage
Prevent invasive meningococcal disease caused by Neisseria meningitidis A, C, Y, W-135
Details
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-67394
Registration
FDA (2020), EMA (2020), HK registration (2022)
Price
HK$1100
Dosage & Schedule
Over 12 months : 1 dose
Peak Incidence Age
1-5 years old and 16-23 years old
Characteristics
- The only ACWY vaccine approved by both FDA & EMA in Hong Kong
High Risk Groups
Borders in dormitories, students planning for overseas studies and travellers to high-risk countries
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, loss of appetite, vomiting, diarrhea and somnolence
Contraindication
- Severe allergic reaction to any component of this vaccine
Vaccine
Imojev
Indication
From 9 months onward
Usage
Prevention of Japanese encephalitis
Details
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-62787
Registration
Australia TGA (2010), Hong Kong CHP (2014)
Price
HK$1850
Dosage & Schedule
9 months to 17 years old: 2 doses series, with interval of 12-24 months
18 years old and above: 1 dose only
Peak Incidence Age
Summer and rainy season
Characteristics
- 99.2% of young children (9 to 18 months old) get protection 28 days after receiving one dose of Japanese encephalitis vaccine
High Risk Groups
Newborn to 14 years old , People who stay outdoor most of the time
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), unusual crying, loss of appetite, headache, vomiting and somnolence
Contraindication
- Infant under 9 months old
- Severe allergic reaction to any component of this vaccine
Vaccine
Prevenar 20
Indication
18 years and above with chronic illness like asthma, COPD, chronic heart disease, diabetes or chronic kidney failure
Usage
Prevention of invasive disease caused by S.pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F and 33F
Details
Manufacturer
Pfizer
HK Registration Number
HK-67820
Registration
HK registration since 2023
Price
HK$2000
Dosage & Schedule
18 years and above : 1 dose
Peak Incidence Age
Above 65 years old
Characteristics
- PCV20 includes all PCV13 serotypes plus 7 extra
High Risk Groups
Immunodeficient individual, functional or anatomic asplenia, cochlear implants
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling)
Contraindication
- Severe allergic reaction to any component of this vaccine or any diphtheria toxoid-containing vaccine
Vaccine
Vaxneuvance 15
Indication
From 6 weeks onwards
Usage
Prevention of invasive disease caused by S.pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F
Details
Manufacturer
MSD
HK Registration Number
HK-67575
Registration
HK registration since 2022
Price
HK$1600
Dosage & Schedule
For babies: 4 doses at aged 2, 4, 6 months and 12-15 months
For aged over 18: 1 dose
Peak Incidence Age
Below 2 and above 65 years old
Characteristics
- PCV15 includes all PCV13 serotypes plus 22F and 33F
- PCV13 and PCV15 can be used interchangeably
High Risk Groups
Infant, immunodeficient individual, functional or anatomic asplenia, cochlear implants
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, loss of appetite, vomiting, diarrhea, upper respiratory tract infection, rash, eczema and itching
Contraindication
- Severe allergic reaction to any component of this vaccine or any diphtheria toxoid-containing vaccine
Vaccine
Prevenar 13
Indication
From 6 weeks onwards
Usage
Prevention of invasive disease caused by S.pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F
Details
Manufacturer
Pfizer
HK Registration Number
HK-59600
Registration
HK registration since 2010
Price
HK$1200
Dosage & Schedule
For aged 6 weeks to under 6 months: 4 doses at aged 2, 4, 6 months and 12-15 months
For aged over 6 to under 12 months: 3 doses (dose 1 & 2 with minimum interval of 4 weeks; dose 2 & 3 with minimum interval of 8 weeks)
For aged over 12 to under 24 months: 2 doses with minimum interval of 8 weeks
For aged over 2: 1 dose
Peak Incidence Age
Below 2 and above 65 years old
Characteristics
- Conjugate vaccine can promote immune memory and provide long-term protection
- Contain extra strains of protection over Prevnar and Synflorix
High Risk Groups
Infant, immunodeficient individual, functional or anatomic asplenia, cochlear implants
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, loss of appetite, vomiting, diarrhea, upper respiratory tract infection, rash, eczema and itching
Contraindication
- Severe allergic reaction to any component of this vaccine or any diphtheria toxoid-containing vaccine
Vaccine
Pneumovax 23
Indication
Over 50 years old
Usage
Prevention of pneumococcal disease caused by 23 serotypes contained in the vaccine
Details
Manufacturer
MSD
HK Registration Number
HK-64170
Registration
HK registration since 2015
Price
HK$400
Dosage & Schedule
1 dose only
Peak Incidence Age
Age 2 and above
Characteristics
- Cover more serotypes than any other pneumococcal vaccine
High Risk Groups
Immunodeficient individual, Functional or anatomic asplenia, Cochlear implants
Common Side Effects
Mild redness and swelling at injection site
Contraindication
- Severe allergic reaction (e.g. anaphylaxis) to any component of Pneumovax 23
Vaccine
ProQuad
Indication
From 12 months onward
Usage
Prevention of measles, mumps, rubella, and varicella
Details
Manufacturer
MSD
HK Registration Number
HK-54831
Registration
HK registration since 2006
Price
HK$800
Dosage & Schedule
2 doses with 3 months interval
Peak Incidence Age
Aged 5-10
Characteristics
- Early protection from 15 months old onwards
High Risk Groups
Young child, Pregnant women
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, vomiting, diarrhea, upper respiratory tract infection, rash and eczema
Contraindication
- Pregnancy
- Severe allergic reaction to any component of this vaccine
- Immunodeficiency
Vaccine
Priorix
Indication
From 12 months onwards
Usage
Prevention of meales, mumps and rubella
Details
Manufacturer
GSK
HK Registration Number
HK-43861
Registration
HK registration since 2015
Price
HK$600
Dosage & Schedule
2 doses with 3 months interval
Peak Incidence Age
Age 5-10
Characteristics
- Early protection from 15 months old onwards
High Risk Groups
Young child, Pregnant women
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), upper respiratory tract infection and rash
Contraindication
- Pregnancy
- Severe allergic reaction to any component of this vaccine
- Immunodeficiency
Vaccine
Twinrix
Indication
18 years and above
Usage
Hepatitis A&B viruses
Details
Manufacturer
GSK
HK Registration Number
HK-43814
Registration
HK registration since 1998
Price
HK$1100
Dosage & Schedule
A series of 3 doses on a 0-,1-,6-month schedule
Peak Incidence Age
Incidence increase with age
Characteristics
- Full response occurs in about 90–100% of individuals
High Risk Groups
Those born in Hong Kong prior to 1988 People who share needles, syringes, or other drug-injection equipment. Travellers to regions with increased rates of hepatitis B. People with chronic liver disease, kidney disease, HIV infection, or diabetes
Common Side Effects
Mild redness and swelling at injection site
Contraindication
- Severe allergic reaction (e.g. anaphylaxis) to any component of Twinrix
Vaccine
Typhim VI
Indication
2 years and above
Usage
Prevention of typhoid
Details
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-36827
Registration
HK registration since 1993
Price
HK$500
Dosage & Schedule
The vaccine should be given at least two weeks prior to departure . Revaccination should be considered every three years for those at continuous risk of infection.
Peak Incidence Age
Those going to typhoid endemic areas
Characteristics
- Antibodies appear after approximately 7 to 15 days after the injection. Persistence of the antibody response is at least 3 years.
High Risk Groups
Those going to typhoid endemic areas, in particular long-stay travellers and those visiting rural areas where food and beverage choices may be limited.
Common Side Effects
Mild redness and swelling at injection site
Contraindication
- Fever
- Severe allergic reaction (e.g. anaphylaxis) to any component of Typhim VI
Vaccine
Verorab
Indication
12 years and above
Usage
Prevention against rabies
Details
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-65375
Registration
HK registration since 2005
Price
HK$800
Dosage & Schedule
Two doses at Day 0 and 7 for primary vaccination.
Peak Incidence Age
Vaccination should be initiated immediately at the slightest risk of rabies contamination.
Characteristics
- It can be used before and after exposure to the rabies virus, as a primary vaccination or as a booster dose.
High Risk Groups
People in contact with potentially rabid animal species (such as dogs, cats, skunks, raccoons, bats). Adults living in or travelling to enzootic areas.
Common Side Effects
Mild redness and swelling at injection site
Contraindication
- Fever
- Severe allergic reaction (e.g. anaphylaxis) to any component of Verorab
Vaccine
Engerix B 20
Indication
From 18 years old
Usage
Adult Hepatitis B Vaccine
Details
Manufacturer
GSK
HK Registration Number
HK-65374
Registration
HK registration since 2017
Price
HK$500
Dosage & Schedule
3 doses: 1-month interval between first and second doses, and 3rd dose 5 months after second dose.
Peak Incidence Age
Born in HK before 1988
Characteristics
- Full response occurs in about 90-95% of individuals
High Risk Groups
Born in HK before 1988 ; People who share needles, syringes, or other drug-injection equipment. Travellers to regions with increased rates of hepatitis B. People with chronic liver disease, kidney disease, HIV infection, or diabetes
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling)
Contraindication
- Severe allergic reaction to any component of this vaccine
Vaccine
Avaxim 160
Indication
From18 years old
Usage
Adult Hepatitis A Vaccine
Details
Manufacturer
Sanofi
HK Registration Number
HK-56399
Registration
HK registration since 2008
Price
HK$1000
Dosage & Schedule
2 doses with 6-12 months apart
Peak Incidence Age
20 - 40 years old
Characteristics
- Protection against Hepatitis A virus starts 28 days after 1st vaccination
High Risk Groups
People with chronic liver disease, IV drug users, and men who have sex with men
Common Side Effects
Fever, injection site reaction (pain / swelling)
Contraindication
- Severe allergic reaction to any component of this vaccine
Suitable for
2 days to 6 months old
Turn around time
2 weeks
Specimen
Urine
Specification
- More than 100 disorders
- Non-invasive and painless method
- FDA approved
Suitable for
All pregnant women (especially those above 35)
Turn around time
2 weeks
Specimen
18ml blood
Specification
To screen for Down syndrome and other chromosomal disorders without risks of miscarriage
Suitable for
In order to protect clients' best interest and to ensure a test accuracy of 99.9%, this test requires gestational age of 7 weeks or above subject to ultrasound examination(CRL>10mm)
Turn around time
One day
Specimen
12 ml blood
Specification
If client completes blood draw at the clinic before 12pm, they will receive an e-report via email before 7 pm. The accuracy of this test is 99.9%
Suitable for
Any sexually active female
Turn around time
5 days
Specimen
Vaginal swab
Specification
Test over 33 types of HPV DNA
Suitable for
People who are vaccinated against HPV
Turn around time
5 working days
Specimen
3ml clotted-blood
Specification
Designed for people who are vaccinated against HPV
The latest HPV antibody test covers all antibodies of the nine-valent HPV vaccine, including HPV6,11,16,18,31,33,45,52,58
According to the degree of antibody-antigen binding, you can accurately determine the level of 9 antibodies through quantitative experiments
Suitable for
Adult 18 years old and above
Turn around time
3 days
Specimen
Blood
Specification
Suitable for
Anyone with allergic symptoms such as hives, skin rash, nasal congestion, runny nose, itchy eyes, etc
Turn around time
2 weeks
Specimen
3ml blood
Specification
Measure the presence of IgE antibodies in the blood. Detect 52 different types of enviornmental allergens and 54 different types of food allergens
Suitable for
Chinese over 25 years old
Turn around time
1 week
Specimen
10ml blood
Specification
Using the lastest BamHi-W gene and CpG technology. EBV DNA load gives better sensitivity and specificity profile as a screening tool for nasopharyngeal cancer
Suitable for
Healthy individuals at all ages, Individual with family history of cancer
Turn around time
6 weeks
Specimen
10ml blood
Specification
A tumour itself is the major source of tumour DNA and dying tumour cells could release small pieces of their DNA into the bloodstream. These pieces are referred to circulating tumour DNA (ctDNA). Owing to its high specificity to tumour, ctDNA is regarded as an effective yet non-invasive cancer biomarker. ctDNA technology could discover the presence of mutation before it develops into malignant tumours
Suitable for
Spouses planning to give birth, particularly for those with hereditary diseases / in consanguine marriage / conducting in-vitro fertilisation
Turn around time
6 weeks
Specimen
6ml blood or 6 buccal swabs
Specification
Carrier with only one copy of mutation for a recessive disease has no symptoms. With two carriers as parents, the child will have up to 25% chance of inheriting a carrier gene and being born with a severe disease. Even if the child is not born with disease, there is still a 50% chance that the child will become a carrier, with the defective gene affecting offspring constantly
Suitable for
From newborn to adult
Turn around time
5 days
Specimen
6ml blood or 4 buccal swabs
Specification
Postnatal Parentage Tests report can be used for private or legal purpose, such as for immigration
Suitable for
10 weeks gestation or above (for female fetus)
Turn around time
10 days
Specimen
20ml blood
Specification
DNA profile of the baby is determined from free-floating fetal cells found in the mother's blood sample. The baby’s profile is compared to the DNA profile of the man tested
RSV vaccine
Vaccine
Arexvy
Indication
Over 60 years old
Usage
RSV infection
Details
Manufacturer
GSK
HK Registration Number
HK-67997
Registration
FDA, EMA, HK registration since 2023
Price
HK$3000
Dosage & Schedule
Only 1 injection
Peak Incidence Age
Over 60 years old
Characteristics
- Protection efficacy of 80-95% for aged 60 and above, with at least one chronic illness
High Risk Groups
60 years old and above with at least one chronic illness (COPD, Diabetes, Heart disease)
Common Side Effects
Mild redness and swelling at injection site
Contraindication
- History of anaphylactic reaction to any component of the vaccine
NEW Herpes Zoster Vaccine
Vaccine
Shingrix
Indication
Over 50 years old
Usage
Prevention of shingles
Details
Manufacturer
GSK
HK Registration Number
HK-66840
Registration
FDA Approved (2017), HK registration since 2021
Price
HK$2900
Dosage & Schedule
2 doses, at least 2 months apart
Peak Incidence Age
Over 50 years old
Characteristics
- Only shingles vaccine provide >90% protection in all segments studied
High Risk Groups
Previous shingles infection, immunodeficient individual
Common Side Effects
Mild redness and swelling at injection site. Occasionally, associated with syncope
Contraindication
- History of anaphylactic reaction to any component of the vaccine
HPV Vaccine
Vaccine
Gardasil 9
Indication
Age 9 or above
Usage
Reduce 90% of cervical cancer, 90-95% of anal cancer and their precancerous growth
Details
Manufacturer
MSD
HK Registration Number
HK-64239
Registration
HK registration since 2015
Price
HK$1800
Dosage & Schedule
Age 9-14: 2 doses series on a 0-,6-month schedule
Age 15 or over: 3 doses series on a 0-,2-,6-month schedule
Peak Incidence Age
Age 26-30, and Age 46-55
Characteristics
- Provide extra 85-90% of protection against Vaginal and Cervical cancer when compare to other HPV vaccine.
High Risk Groups
Recurrent HPV infection, Immunodeficient individual, Smoker
Common Side Effects
Mild redness and swelling at injection site. Occasionally, fever or headache might occur
Contraindication
- Hypersensitivity, including severe allergic reactions to yeast (a vaccine component), or after a previous dose of GARDASIL 9 or GARDASIL
- Pregnant women
- Those with fever or suffering from moderate to severe illness
Meningococcal Group B Vaccine
Vaccine
Bexsero
Indication
2 months old onwards
Usage
Prevent invasive meningococcal disease by Neisseria meningitidis B
Details
Manufacturer
GSK
HK Registration Number
HK-66268
Registration
HK registration since 2019
Price
HK$1500
Dosage & Schedule
2-23 months old : 3 doses, at least 2 months between each dose
2 years old and above : 2 doses, at least 1 month apart
Peak Incidence Age
Aged below 1, and 16-23
Characteristics
- The only Meningococcal B vaccine indicated for paediatric patients
- Though Hong Kong has a low meningococcal infection rate, vaccination is still recommended for high-risk group
High Risk Groups
Immunodeficient individual, borders in dormitorie, students planning for overseas studies and travellers to high-risk countries
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), unusual crying, irritability, loss of appetite, vomiting, diarrhea, somnolence and rash
Contraindication
- Severe allergic reaction to any component of this vaccine
Quadrivalent Flu Vaccine (Injectable)
Vaccine
Quadrivalent Flu Vaccine
Indication
Aged 6 months onwards
Usage
Influenza A&B and its complications
Details
Manufacturer
Sanofi Pasteur, GSK
HK Registration Number
HK-65577, HK-62234
Registration
HK registration
Price
HK$280
Dosage & Schedule
1 dose annually
2 doses with minimum interval of 4 weeks for child below aged 9 who has never received any seasonal influenza vaccine
Peak Incidence Age
Under 12 and over 50 years old
Characteristics
- Protection begin 2 weeks after vaccination
High Risk Groups
Children younger than 5, but especially children younger than 2 years, elderly and those with weaken immunity.
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability and headache
Contraindication
- Severe allergic reaction to any component of this vaccine
Quadrivalent Flu Vaccine (Intranasal)
Vaccine
Flumist
Indication
Aged 2-49
Usage
Influenza A&B and its complications
Details
Manufacturer
AstraZeneca
HK Registration Number
HK-65690
Registration
HK registration 2018
Price
HK$440
Dosage & Schedule
1 dose annually
2 doses with minimum interval of 4 weeks for child below aged 9 who has never received any seasonal influenza vaccine
Peak Incidence Age
Under 12
Characteristics
- Protection begin 2 weeks after vaccination
High Risk Groups
Children younger than 5 years old
Common Side Effects
Fever, runny nose, nasal congestion, sore throat
Contraindication
- Severe allergic reaction to any component of Flumist
- Children aged 2 to 5 years with history recurrent wheezing
- Asthma sufferer and pregnant lady
- Concomitant aspirin therapy
Nimenrix - Meningococcal (Group A,C,Y,W-135) Vaccine
Vaccine
Nimenrix
Indication
6 weeks and above
Usage
Prevent invasive meningococcal disease caused by Neisseria meningitidis A, C, Y, W-135
Details
Manufacturer
Pfizer
HK Registration Number
HK-62095
Registration
HK registration since 2013
Price
HK$1100
Dosage & Schedule
For aged 6 weeks to 5 months: 3 doses, minimum 2-month interval between first two doses, then 1 booster dose at 12 months old or above
For aged 6-11 months: 2 doses with minimum 2-month interval and second dose given at 12 months old or above
Over 12 months : 1 dose
Peak Incidence Age
Under 12 months, and between 16-23 years old
Characteristics
- Contain extra Y and W-135 strain than the China meninococcal vaccine
- Can be given as early as 6 weeks old
- Though Hong Kong has a low meningococcal infection rate, vaccination is still recommended for high-risk group
High Risk Groups
Under 1 year old, borders in dormitories, students planning for overseas studies and travellers to high-risk countries
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, loss of appetite, vomiting, diarrhea and somnolence
Contraindication
- Severe allergic reaction to any component of this vaccine
MenQuadfi - Meningococcal (Group A,C,Y,W-135) Vaccine
Vaccine
MenQuadfi
Indication
12 months old and above
Usage
Prevent invasive meningococcal disease caused by Neisseria meningitidis A, C, Y, W-135
Details
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-67394
Registration
FDA (2020), EMA (2020), HK registration (2022)
Price
HK$1100
Dosage & Schedule
Over 12 months : 1 dose
Peak Incidence Age
1-5 years old and 16-23 years old
Characteristics
- The only ACWY vaccine approved by both FDA & EMA in Hong Kong
High Risk Groups
Borders in dormitories, students planning for overseas studies and travellers to high-risk countries
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, loss of appetite, vomiting, diarrhea and somnolence
Contraindication
- Severe allergic reaction to any component of this vaccine
Japanese Encephalitis Vaccine
Vaccine
Imojev
Indication
From 9 months onward
Usage
Prevention of Japanese encephalitis
Details
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-62787
Registration
Australia TGA (2010), Hong Kong CHP (2014)
Price
HK$1850
Dosage & Schedule
9 months to 17 years old: 2 doses series, with interval of 12-24 months
18 years old and above: 1 dose only
Peak Incidence Age
Summer and rainy season
Characteristics
- 99.2% of young children (9 to 18 months old) get protection 28 days after receiving one dose of Japanese encephalitis vaccine
High Risk Groups
Newborn to 14 years old , People who stay outdoor most of the time
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), unusual crying, loss of appetite, headache, vomiting and somnolence
Contraindication
- Infant under 9 months old
- Severe allergic reaction to any component of this vaccine
Rotavirus Vaccine
Vaccine
RotaTeq
Indication
From 6 to 32 weeks infants
Usage
Rotavirus gastroenteritis caused by G1, G2, G3, G4 & G9 types
Details
Manufacturer
MSD
HK Registration Number
HK-55037
Registration
HK registration since 2006
Price
HK$520
Dosage & Schedule
3 doses with at least 4 weeks apart, first dose to be taken before 12 weeks old
Peak Incidence Age
6 to 24 months
Characteristics
- Pentavalent vaccine
High Risk Groups
4 to 23 months
Common Side Effects
Fever, irritability, loss of appetite, vomiting, diarrhea
Contraindication
- Severe allergic reaction to any component of this vaccine
- History of intussusception or uncorrected congenital malformation of the gastrointestinal tract that would predispose the infant to intussusception
- History of severe combined immunodeficiency disease
Rotavirus Vaccine
Vaccine
Rotarix
Indication
From 6 to 24 weeks infants
Usage
Rotavirus gastroenteritis caused by G1 and non-G1 types
Details
Manufacturer
GSK
HK Registration Number
HK-54546
Registration
HK registration since 2006
Price
HK$780
Dosage & Schedule
2 doses with at least 4 weeks apart, first dose to be taken before 20 weeks old
Peak Incidence Age
6 to 24 months
Characteristics
- Early protction, infant can finished the 2 doses course as early as 10 weeks old
High Risk Groups
4 to 23 months
Common Side Effects
Fever, irritability, loss of appetite, vomiting, diarrhea
Contraindication
- Severe allergic reaction to any component of this vaccine
- History of intussusception or uncorrected congenital malformation of the gastrointestinal tract that would predispose the infant to intussusception
- History of severe combined immunodeficiency disease
6-in-1 Vaccine
Vaccine
Infanrix-Hexa
Indication
From 6 weeks onwards
Usage
Prevention of diphtheria, tetanus, pertussis, poliomyelitis, invasive disease due to Haemophilus influenzae type b and hepatitis B
Details
Manufacturer
GSK
HK Registration Number
HK-64010
Registration
HK registration since 2015
Price
HK$800
Dosage & Schedule
4 doses at aged 2, 4, 6 months and 15-18 months
Peak Incidence Age
Infant
Characteristics
- 30-40% more Pertussis prevention than traditional DTaP-IPV vaccine
- Combine 5in1 & Hepatitis B vaccine, can reduce the total number of injections from 10 to 4
High Risk Groups
Infant
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), injection nodule, unusual crying, irritability, loss of appetite, vomiting, diarrhea and somnolence
Contraindication
- Severe allergic reaction to any component of this vaccine
- Encephalopathy of unknown cause, occurring within 7 days following previous vaccination with a pertussis containing vaccine
5-in-1 Vaccine
Vaccine
Pentaxim
Indication
From 2 months onward
Usage
Prevention of diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b.
Details
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-56018
Registration
HK registration since 2007
Price
HK$780
Dosage & Schedule
4 doses at 2, 4, 6 months and 15-18 months
Peak Incidence Age
Infant
Characteristics
- Combine DTaP-IPV & Hib vaccine, can reduce the total number of injections from 8 to 4
High Risk Groups
Infant
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), injection nodule, unusual crying, irritability, loss of appetite, vomiting, diarrhea and somnolence
Contraindication
- Severe allergic reaction to any component of this vaccine
- Encephalopathy of unknown cause, occurring within 7 days following previous vaccination with a pertussis containing vaccine
20-Valent Pneumococcal Conjugate Vaccine (PCV20)
Vaccine
Prevenar 20
Indication
18 years and above with chronic illness like asthma, COPD, chronic heart disease, diabetes or chronic kidney failure
Usage
Prevention of invasive disease caused by S.pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F and 33F
Details
Manufacturer
Pfizer
HK Registration Number
HK-67820
Registration
HK registration since 2023
Price
HK$2000
Dosage & Schedule
18 years and above : 1 dose
Peak Incidence Age
Above 65 years old
Characteristics
- PCV20 includes all PCV13 serotypes plus 7 extra
High Risk Groups
Immunodeficient individual, functional or anatomic asplenia, cochlear implants
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling)
Contraindication
- Severe allergic reaction to any component of this vaccine or any diphtheria toxoid-containing vaccine
Haemophilus influenza type b (Hib) vaccine
Vaccine
Act-HIB
Indication
2 months to 5 years old
Usage
Prevention of Haemophilus influenza type b infection
Details
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-37568
Registration
HK registration since 1994
Price
HK$350
Dosage & Schedule
For aged 1.5-6 months: 4 doses with minimum 4-week interval for the first three doses, fourth dose at least 8 weeks after third dose and at 12 months old or above
For aged 7-11 months: 3 doses with minimum 4-week interval for the first two doses, third dose at least 8 weeks after second dose and at 12 months old or above
For aged 12-14 months: 2 doses with minimum 8-week interval
For aged 15-59 months: 1 dose
Peak Incidence Age
Infant
Characteristics
- To reduce the number of injections, 5-in-1 or 6-in-1 vaccine can be considered as they already included this vaccine
High Risk Groups
3 months to 3 years old
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, loss of appetite and somnolence
Contraindication
- Severe allergic reaction to any component of this vaccine
15-Valent Pneumococcal Conjugate Vaccine (PCV15)
Vaccine
Vaxneuvance 15
Indication
From 6 weeks onwards
Usage
Prevention of invasive disease caused by S.pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F
Details
Manufacturer
MSD
HK Registration Number
HK-67575
Registration
HK registration since 2022
Price
HK$1600
Dosage & Schedule
For babies: 4 doses at aged 2, 4, 6 months and 12-15 months
For aged over 18: 1 dose
Peak Incidence Age
Below 2 and above 65 years old
Characteristics
- PCV15 includes all PCV13 serotypes plus 22F and 33F
- PCV13 and PCV15 can be used interchangeably
High Risk Groups
Infant, immunodeficient individual, functional or anatomic asplenia, cochlear implants
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, loss of appetite, vomiting, diarrhea, upper respiratory tract infection, rash, eczema and itching
Contraindication
- Severe allergic reaction to any component of this vaccine or any diphtheria toxoid-containing vaccine
13-Valent Pneumococcal Conjugate Vaccine (PCV13)
Vaccine
Prevenar 13
Indication
From 6 weeks onwards
Usage
Prevention of invasive disease caused by S.pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F
Details
Manufacturer
Pfizer
HK Registration Number
HK-59600
Registration
HK registration since 2010
Price
HK$1200
Dosage & Schedule
For aged 6 weeks to under 6 months: 4 doses at aged 2, 4, 6 months and 12-15 months
For aged over 6 to under 12 months: 3 doses (dose 1 & 2 with minimum interval of 4 weeks; dose 2 & 3 with minimum interval of 8 weeks)
For aged over 12 to under 24 months: 2 doses with minimum interval of 8 weeks
For aged over 2: 1 dose
Peak Incidence Age
Below 2 and above 65 years old
Characteristics
- Conjugate vaccine can promote immune memory and provide long-term protection
- Contain extra strains of protection over Prevnar and Synflorix
High Risk Groups
Infant, immunodeficient individual, functional or anatomic asplenia, cochlear implants
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, loss of appetite, vomiting, diarrhea, upper respiratory tract infection, rash, eczema and itching
Contraindication
- Severe allergic reaction to any component of this vaccine or any diphtheria toxoid-containing vaccine
23-Valent Pneumococcal Conjugate Vaccine
Vaccine
Pneumovax 23
Indication
Over 50 years old
Usage
Prevention of pneumococcal disease caused by 23 serotypes contained in the vaccine
Details
Manufacturer
MSD
HK Registration Number
HK-64170
Registration
HK registration since 2015
Price
HK$400
Dosage & Schedule
1 dose only
Peak Incidence Age
Age 2 and above
Characteristics
- Cover more serotypes than any other pneumococcal vaccine
High Risk Groups
Immunodeficient individual, Functional or anatomic asplenia, Cochlear implants
Common Side Effects
Mild redness and swelling at injection site
Contraindication
- Severe allergic reaction (e.g. anaphylaxis) to any component of Pneumovax 23
MMRV Vaccine
Vaccine
ProQuad
Indication
From 12 months onward
Usage
Prevention of measles, mumps, rubella, and varicella
Details
Manufacturer
MSD
HK Registration Number
HK-54831
Registration
HK registration since 2006
Price
HK$800
Dosage & Schedule
2 doses with 3 months interval
Peak Incidence Age
Aged 5-10
Characteristics
- Early protection from 15 months old onwards
High Risk Groups
Young child, Pregnant women
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, vomiting, diarrhea, upper respiratory tract infection, rash and eczema
Contraindication
- Pregnancy
- Severe allergic reaction to any component of this vaccine
- Immunodeficiency
MMR Vaccine
Vaccine
Priorix
Indication
From 12 months onwards
Usage
Prevention of meales, mumps and rubella
Details
Manufacturer
GSK
HK Registration Number
HK-43861
Registration
HK registration since 2015
Price
HK$600
Dosage & Schedule
2 doses with 3 months interval
Peak Incidence Age
Age 5-10
Characteristics
- Early protection from 15 months old onwards
High Risk Groups
Young child, Pregnant women
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), upper respiratory tract infection and rash
Contraindication
- Pregnancy
- Severe allergic reaction to any component of this vaccine
- Immunodeficiency
Chickenpox vaccine
Vaccine
Varivax
Indication
From 12 months old onwards
Usage
Prevention of chickenpox
Details
Manufacturer
MSD
HK Registration Number
HK-39958
Registration
HK registration since 1996
Price
HK$600
Dosage & Schedule
2 doses with at least 1 month interval
Peak Incidence Age
Age 10 and below
Characteristics
- Early protection from 15 months old onwards
High Risk Groups
Young child, Pregnant women
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, vomiting, diarrhea, upper respiratory tract infection, rash and eczema
Contraindication
- Pregnancy
- Severe allergic reaction to any component of this vaccine
- Immunodeficiency
Hepatitis A&B vaccine
Vaccine
Twinrix
Indication
18 years and above
Usage
Hepatitis A&B viruses
Details
Manufacturer
GSK
HK Registration Number
HK-43814
Registration
HK registration since 1998
Price
HK$1100
Dosage & Schedule
A series of 3 doses on a 0-,1-,6-month schedule
Peak Incidence Age
Incidence increase with age
Characteristics
- Full response occurs in about 90–100% of individuals
High Risk Groups
Those born in Hong Kong prior to 1988 People who share needles, syringes, or other drug-injection equipment. Travellers to regions with increased rates of hepatitis B. People with chronic liver disease, kidney disease, HIV infection, or diabetes
Common Side Effects
Mild redness and swelling at injection site
Contraindication
- Severe allergic reaction (e.g. anaphylaxis) to any component of Twinrix
Child Hepatitis A Vaccine
Vaccine
Havrix 720 Junior
Indication
12 months of age and older
Usage
Child Hepatitis A virus
Details
Manufacturer
GSK
HK Registration Number
HK-42693
Registration
HK registration since 1997
Price
HK$420
Dosage & Schedule
2 doses with 6 -12 months apart
Peak Incidence Age
Aged 9-12 and adolescence. Incidence increase with age
Characteristics
- Protecton against Hepatitis A virus starts 28 days after 1st vaccination
High Risk Groups
Child care centre attendee and children who have started eating high-risk food such as fish and shellfish, Travellers to endemic areas of hepatitis A, Persons with chronic liver diseases.
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability, loss of appetite, vomiting, diarrhea, headache, somnolence and arthralgia
Contraindication
- Severe allergic reaction to any component of this vaccine
Child Hepatitis B Vaccine
Vaccine
Engerix-B 10
Indication
From birth
Usage
Child Hepatitis B virus
Details
Manufacturer
MSD
HK Registration Number
HK-50265
Registration
HK registration since 2002
Price
HK$400
Dosage & Schedule
3 doses: 1-month interval between first and second doses, and third dose 5 months after second dose
Peak Incidence Age
At birth
Characteristics
- Full response occurs in about 90–95% of individuals
High Risk Groups
Babies born to carrier mothers. People who share needles, syringes, or other drug-injection equipment. Travellers to regions with increased rates of hepatitis B. People with chronic liver disease, kidney disease, HIV infection, or diabetes
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling), irritability and headache
Contraindication
- Severe allergic reaction to any component of this vaccine
Typhoid vaccine
Vaccine
Typhim VI
Indication
2 years and above
Usage
Prevention of typhoid
Details
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-36827
Registration
HK registration since 1993
Price
HK$500
Dosage & Schedule
The vaccine should be given at least two weeks prior to departure . Revaccination should be considered every three years for those at continuous risk of infection.
Peak Incidence Age
Those going to typhoid endemic areas
Characteristics
- Antibodies appear after approximately 7 to 15 days after the injection. Persistence of the antibody response is at least 3 years.
High Risk Groups
Those going to typhoid endemic areas, in particular long-stay travellers and those visiting rural areas where food and beverage choices may be limited.
Common Side Effects
Mild redness and swelling at injection site
Contraindication
- Fever
- Severe allergic reaction (e.g. anaphylaxis) to any component of Typhim VI
Rabies vaccine
Vaccine
Verorab
Indication
12 years and above
Usage
Prevention against rabies
Details
Manufacturer
Sanofi Pasteur
HK Registration Number
HK-65375
Registration
HK registration since 2005
Price
HK$800
Dosage & Schedule
Two doses at Day 0 and 7 for primary vaccination.
Peak Incidence Age
Vaccination should be initiated immediately at the slightest risk of rabies contamination.
Characteristics
- It can be used before and after exposure to the rabies virus, as a primary vaccination or as a booster dose.
High Risk Groups
People in contact with potentially rabid animal species (such as dogs, cats, skunks, raccoons, bats). Adults living in or travelling to enzootic areas.
Common Side Effects
Mild redness and swelling at injection site
Contraindication
- Fever
- Severe allergic reaction (e.g. anaphylaxis) to any component of Verorab
Adult Hepatitis B Vaccine
Vaccine
Engerix B 20
Indication
From 18 years old
Usage
Adult Hepatitis B Vaccine
Details
Manufacturer
GSK
HK Registration Number
HK-65374
Registration
HK registration since 2017
Price
HK$500
Dosage & Schedule
3 doses: 1-month interval between first and second doses, and 3rd dose 5 months after second dose.
Peak Incidence Age
Born in HK before 1988
Characteristics
- Full response occurs in about 90-95% of individuals
High Risk Groups
Born in HK before 1988 ; People who share needles, syringes, or other drug-injection equipment. Travellers to regions with increased rates of hepatitis B. People with chronic liver disease, kidney disease, HIV infection, or diabetes
Common Side Effects
Fever, injection site reaction (pain/erythema/swelling)
Contraindication
- Severe allergic reaction to any component of this vaccine
Adult Hepatitis A Vaccine
Vaccine
Avaxim 160
Indication
From18 years old
Usage
Adult Hepatitis A Vaccine
Details
Manufacturer
Sanofi
HK Registration Number
HK-56399
Registration
HK registration since 2008
Price
HK$1000
Dosage & Schedule
2 doses with 6-12 months apart
Peak Incidence Age
20 - 40 years old
Characteristics
- Protection against Hepatitis A virus starts 28 days after 1st vaccination
High Risk Groups
People with chronic liver disease, IV drug users, and men who have sex with men
Common Side Effects
Fever, injection site reaction (pain / swelling)
Contraindication
- Severe allergic reaction to any component of this vaccine
Metabolic disorders screening
Suitable for
2 days to 6 months old
Turn around time
2 weeks
Specimen
Urine
Specification
- More than 100 disorders
- Non-invasive and painless method
- FDA approved
Non-invasive Prenatal Screening (NIPT)
Suitable for
All pregnant women (especially those above 35)
Turn around time
2 weeks
Specimen
18ml blood
Specification
To screen for Down syndrome and other chromosomal disorders without risks of miscarriage
Maternal Blood Y-DNA Rapid Test
Suitable for
In order to protect clients' best interest and to ensure a test accuracy of 99.9%, this test requires gestational age of 7 weeks or above subject to ultrasound examination(CRL>10mm)
Turn around time
One day
Specimen
12 ml blood
Specification
If client completes blood draw at the clinic before 12pm, they will receive an e-report via email before 7 pm. The accuracy of this test is 99.9%
HPV DNA Self Collection Test
Suitable for
Any sexually active female
Turn around time
5 days
Specimen
Vaginal swab
Specification
Test over 33 types of HPV DNA
HPV Antibody Test (Upgrade)
Suitable for
People who are vaccinated against HPV
Turn around time
5 working days
Specimen
3ml clotted-blood
Specification
Designed for people who are vaccinated against HPV
The latest HPV antibody test covers all antibodies of the nine-valent HPV vaccine, including HPV6,11,16,18,31,33,45,52,58
According to the degree of antibody-antigen binding, you can accurately determine the level of 9 antibodies through quantitative experiments
Carrier Risk Assessment Test
Suitable for
Spouses planning to give birth, particularly for those with hereditary diseases / in consanguine marriage / conducting in-vitro fertilisation
Turn around time
6 weeks
Specimen
6ml blood or 6 buccal swabs
Specification
Carrier with only one copy of mutation for a recessive disease has no symptoms. With two carriers as parents, the child will have up to 25% chance of inheriting a carrier gene and being born with a severe disease. Even if the child is not born with disease, there is still a 50% chance that the child will become a carrier, with the defective gene affecting offspring constantly
EBV DNA Test - Early Nasopharyngeal Cancer Detection
Suitable for
Chinese over 25 years old
Turn around time
1 week
Specimen
10ml blood
Specification
Using the lastest BamHi-W gene and CpG technology. EBV DNA load gives better sensitivity and specificity profile as a screening tool for nasopharyngeal cancer
ctDNA - Early Cancer Screening
Suitable for
Healthy individuals at all ages, Individual with family history of cancer
Turn around time
6 weeks
Specimen
10ml blood
Specification
A tumour itself is the major source of tumour DNA and dying tumour cells could release small pieces of their DNA into the bloodstream. These pieces are referred to circulating tumour DNA (ctDNA). Owing to its high specificity to tumour, ctDNA is regarded as an effective yet non-invasive cancer biomarker. ctDNA technology could discover the presence of mutation before it develops into malignant tumours
Allergy Tests
Suitable for
Anyone with allergic symptoms such as hives, skin rash, nasal congestion, runny nose, itchy eyes, etc
Turn around time
2 weeks
Specimen
3ml blood
Specification
Measure the presence of IgE antibodies in the blood. Detect 52 different types of enviornmental allergens and 54 different types of food allergens
Postnatal Parentage Tests
Suitable for
From newborn to adult
Turn around time
5 days
Specimen
6ml blood or 4 buccal swabs
Specification
Postnatal Parentage Tests report can be used for private or legal purpose, such as for immigration
DNA Diagnostic Center Non-invasive Prenatal Paternity Test
Suitable for
10 weeks gestation or above (for female fetus)
Turn around time
10 days
Specimen
20ml blood
Specification
DNA profile of the baby is determined from free-floating fetal cells found in the mother's blood sample. The baby’s profile is compared to the DNA profile of the man tested
Body check plan
Suitable for
Adult 18 years old and above
Turn around time
3 days
Specimen
Blood
Specification